Dyne Therapeutics Inc
DYN
ISIN US26818M1080 / Valor 56806425
Dyne Therapeutics Inc
UMushroom community rating:
About company
Dyne Therapeutics Inc is a biotechnology firm dedicated to developing innovative treatments for serious muscle diseases. Leveraging its proprietary FORCE™ platform, the company aims to address the challenges associated with delivering therapeutics to muscle tissue, focusing on the advancement of oligonucleotide therapeutic candidates. Founded with a clear mission to transform the lives of those afflicted by muscle diseases, Dyne has built a robust team with extensive expertise in muscle disease, rare disorders, drug development, manufacturing, and the commercialization of novel therapeutics. Additionally, the company benefits from the guidance of a scientific advisory board composed of renowned experts in muscle disease drug discovery, development, and nucleic acid therapeutics, underscoring its commitment to pioneering breakthroughs in the field.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
3474 M
Market cap (USD)
631,572
Daily traded volume (Shares)
35.225 / 34.08
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
